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INTRODUCTION
Sexually transmitted infections are believed to have existed since ancient  times. Their 
transmission is related to human nature and frailities.  They can have serious effects on the 
body, on the mind and can result in serious reproductive morbidity and mortality.
Extensive  efforts  have  been  devoted  to  research  and  intervention  of  HIV/AIDS,  as 
compared  with  very  little  attention  been  paid  to  other  STI's   STI's  acts  as  cofactors  (or) 
facilitators for HIV transmission, support the argument that research on STD's other than HIV/
AIDS can also contribute to better insight into control of HIV infection.
Wasserheit1 has  called  this  relationship  "Epidemiological  Synergy",  a  phrase  that 
emphasises STI's enhance HIV-1 tranmission
Classical STIs, both ulcerative and non ulcerative could facilitate HIV-1 transmission by 
increasing either the infectiousness of index case, the succeptibility of the partner (or) both.
REVIEW OF LITERATURE
AIDS (Acquired  Immuno defeciency  syndrome)  represents  the  late  clinical  stage  of 
infection with human  immunodefeciency virus. The syndrome was first recognised in 1981 
when reports came from New york and california (USA) of a sudden increase in incidence of 
two very rare diseases,  Kaposis  sarcoma and pneumocystis  Jeroveci (at  that time P.carinii) 
pneumonia, in young adults who were  Homosexuals (or) Intravenous drugs abusers.  For a 
short  time the  new disease  was called "gay related immuno deficiency syndrome",  but  by 
September of 1982, the CDC published a case definition using the current designation of AIDS 
in print and it was rapidly adopted by researchers.
Human immuno deficiency virus was first isolated in france in 1983 by Barre-Sinoussi 
et al2 in the laboratory of Luc  Montagnier as lymphadenopathy associated virus. In 1984 four 
papers were published in one issue of `Science' by  Gallo et al3   who designated the virus, 
Human  T-cell  lymphotropic  virus  type  III.  In  1986  International  committee  on  virus 
nomenculature decided on the generic name human immodeficiency virus.
In 1986 montagniers group discovered a new type of  HIV in west Africa and labelled it 
as HIV -2.
Enzyme  Linked  immunosorbent  assay  (ELISA)  technique  to  detect  the  presence  of 
Antibodies in blood against HIV was developed in 1984.
In 1993 CDC classification system called, any HIV individual with a CD4+ T cell count 
less than 200 cells / ml has AIDS by definition regardless of the presence of symptoms (or) 
oppurtunitic diseases.
Indian Scenario
Anti  HIV  -  Antibodies  were  first  detected  among  sex  workers  at  Madras  Medical 
College, Chennai, South India.
National AIDS control organisation in 1999 gave the clinical case definition for AIDS. 
Using two positive screening test for HIV infection (ELISA) and any one of the oppurtunistic 
infections, designated as AIDS definining illness.
Global notes of HIV AIDS epidemic Dec 2004
Particulars
No.of persons 
living with HIV 
AIDS
Persons newly 
infected with 
HIV during 
2004
AIDS deaths 
during 2004
Total 39.4 million 4.9 million 3.1 million
Adults 37.2 million 4.3 million 2.6 million
Children below 15 
years
2.2 million 640000 510,000
Relationship between STD & HIV infection
a. The predominant mode of transmission of both HIV infection and other STD is through 
sexual route.
b. STD are biological cofactors for both acquisition and transmission of HIV-1 infection.
c. Concurrent HIV infection alters the natural history  of classic STD.
d. STD are markers for high risk behaviour for HIV infections.
e. Preventive  measures  and  target  audience  are  the  same  for  prevention  of  sexual 
transmission of HIV and STD.
f. STD clinical services are important access point for high risk persons for education on 
prevention and counselling, for HIV infection. 
g. Trends in STD incidence and prevalence can be useful indicators of changes in sexual 
behaviours and valuable for determining the impact of HIV/AIDS control programme.
The prevalence of HIV infection among STD clinic attendees, was found higher among 
ulcerative STD patients than non-ulcerative STD patients.4,5
STD Increased risk for HIV infection
Clinical 
Exacerbation*
N. Gonorrhoea +/- 3-5 times +/-
Chlamydia trachomatis + 3-5 times +/-
Trichomonas vaginalis + 3-5 times -
Charcroid + 2-5 times +
Syphilis + 3-9 times +
Genital Herpes + 2 times +
Granuloma Inguinale + +/-
Human  Papilloma  virus 
infection
+ +
LGV + +/-
Hepatitis B - +/-
Possible Mechanisms of Cofactor effect of Ulcerative and Non-ulcertative STD on HIV 
transmission
1. Lack of Mechanical skin / mucous Membrane endocervical epithelium barrier makes an 
easy viral exit and entry due to ulceration (or) microulceration.
2. Increased  presence  of  activated,  HIV  suceptible  cells  in  the  genital  tract,  (the 
succeptibility cofactor effect).
eg. Haemophilus ducreyi evokes a cell mediated immune response which attracts HIV 
succeptible cells. H. Ducreyi may contain certain  T-cell stimulating antigen.
In tissues coinfected with HSV-1, HIV 1 virions are able to infect keratinocytes despite 
the lack of CD4 receptors.
Viral STD may change cellular chemokine receptors to the advantage of HIV gaining 
entry into the suceptible cells, as shown recently in studies of cytomegalovirus.
3. Genital ulcers bleed frequently during sexual intercourse resulting in potential increases 
in HIV infectiousness (the infectivity cofactor effect).
4. Presence of HIV-1 in genital ulcer exudate in HIV infected individuals confirmed by 
culture  and PCR (the infectivitity cofactor effect)7.
5. Increased number of HIV containing cells in both ulcerative and inflammatory genital 
secretions (the infectivity cofactor effect).
6. Increased shedding of HIV in the genital tract (the infectivity cofactor effect) particuarly 
in  non-ulcerative  STD probably  by  HIV infected  inflammatory  cells  as  part  of  the 
normal host response.
eg.  A significant  increase  in  detection of  HIV -1 DNA in cervico vaginal  fluids  of 
patients with gonorrhoea, chlamydia infection.
7. Increasing HIV replication by certain ulcerative STD pathogens (eg. Treponema pallium 
Lipoproteins)  and/or  increasing  number  of  receptors  expressed  per  cell  receptive  to 
HIV-19
(eg.) H. Ducreyi lipo-oligosaccharide may increase the number of CCR5 receptors on a 
macrophage cell line.
8. For cervicitis specifically three potential mechanisms have been suggested to explain the 
observed relationship of cervicitis and HIV infection.
a. Recruitment  of inflammatory cells  to the cervical  mucosa results  in increased 
concentration  of  HIV-1  infected  CD4 lymphocytes  and  infected  monocytes  / 
macrophages.
b. HIV replication is increased in the presence of an inflammatory milieu, through 
the  generation  of  reactive  oxygen  products  secreted  by  granulocytes  and 
secondary to cell activation which is mediated by inflammatory cytokines (IL-1 
(or) TNF-α).
c. Microulceration and friable mucosal tissue associated with cervicitis can provide 
a portal of exit of infected cells.
9. Bacterial vaginosis may facilitate HIV transmission.
Schmid  et  al  have  summarised  all  possible  mechanisms  from  research  studies  of 
different workers 
a. Lactobacilli  produce  lactic  acid  which  inhibits  growth  of  may  organisms 
associated with BV13.  It  also produces hydrogen peroxide which is  toxic to a 
number of organisms including HIV.
b. A low vaginal Ph may inhibit CD4 lymphocyte activation and there fore decrease 
HIV target cells in vagina. A high vaginal pH in BV may therefore make the 
vagina more conductive to HIV survival and adherence.
c. BV has also been shown to increase intravaginal levels of IL-10 which increases 
succeptibility of macrophages to HIV.
d. A  heat  stable  protein  elobarated  by  Gardenerella  vaginalis  increases  the 
production of HIV by HIV infected cells by as much as 77 fold. Mycoplasma 
hominis  is  the  most  potent  inducer  of  HIV expression  among sexual  vaginal 
bacterial species studied.
EFFECT OF STD MANAGEMENT ON HIV TRANSMISSION
If STD cofactors effects are strong and wherever STD are prevalent STD management 
can be strong strategy for HIV prevention.
In a study conducted in Malawi. The results showed that HIV positive men with urethritis had HIV I 
concentrations in the seminal plasma eight times higher than those in seropositive men without 
urethritis. After urethritis patients were treated for their STD, the concentration of HIV-1 RNA in 
semen decreased significantly.10
Ghys and coworkers found a significant increase in detection of HIV-1 DNA in cervico 
vaginal ulcer (or) cervical mucopus. A week after STD treatment detection of HIV in these 
secretions decreased from 42% to 21%; changes in detection rate were not observed in women 
whose STD are not cured.
A randomized control  trial  was  done to  evaluate  the  impact  of  improved STD case 
management   as  per  the  WHO  recommended  syndromic  STD  management  guidelines  at 
primary care level on the incidence of HIV infection in rural tanzania over a two years period.
The  Mwanza  trial  demonstrated  a  42%  reduction  in  new  sexually  transmitted  HIV 
infection in the intervention communities compared with the control communities.14
However,  in  another   community  based  randomized  trial  conducted  in  the  RAKAI 
district, uganda between 1994 and 1998, no effect on HIV incidence was seen, either over all 
(or) in sub groups including initially discordant couples (or) pregnant women. The unexpected 
result from Rakai studies might be due to several factors.
Possible Explanations include
a. Differences in stages of HIV -1 epidemic 
b. Potential difference in frequency of incurable STD like genital herpes.
c. Greater  importance  of  symptomatic  than   asymptomatic  STD  for  HIV  -1 
transmission 
d. Greater  effectiveness  of  continously  available  services  (mwanza)  than  of 
intermittent mass treatment to control rapid STD reinfection in Rakai.
Even if STD cofactor effects on HIV transmission would be weaker than previously 
thought,  improving  STD management  remains  an important  component  of  HIV prevention 
programme.15
IMPACT OF HIV INFECTION / AIDS ON OTHER STD
The natural history and manifestations of classic STD is altered by concurrent HIV infection. It has 
been noted from the beginning of the AIDS epidemic.
SYPHILIS 
 HIV   appears  to  affect  the  epidemiology,  clinical  manifestations  and  treatment  of 
syphilis. Although the incidence of syphilis rose dramatically in the united states in the late 
1980's especially among the inner city African - American communities, no such trend was 
reported from India.16,17,18
A more aggressive course and unusual clinical presentations have been seen in HIV 
positive individuals. Neurological complications have been reported more frequently and occur 
earlier in HIV positive patients. In patients with HIV infection syphilis follows a malignant and 
protracted course that challenges our diagnostic and therapeutic abilities.
Primary Syphilis
In  HIV seropositive  individuals the primary chancre presents in various morphological forms 
including, the usually painless chancre becoming painful due to secondary infection, multiple chancres, 
giant primary chancre, phagedenic, erosive lesions .
Secondary Syphilis
Lues maligna19,20 (malignant syphilis)  characterised by nodulo ulcerative lesions with systemic 
symptoms, with florid cutaneous and mucocutaneous lesions, pustular, nodular necrotising secondary 
lesions, hyperkeratotic verrucous plaque type lesions, 21  Rapid progression to secondary syphilis with 
persistence of primary chancre.22 Altered morphological forms like palmoplantar keratoderma, livedo 
vasculitis of trunk, vesicular and hyperkeratotic form have also been described.23,24 General symptoms 
like head ache, high fever and weakness are about 60 times more frequent in HIV positive individuals 
than  HIV  negative  individuals.25 Shorter  latent  period  before  development  of  meningo  vascular 
syphilis, increasing incidence of early neurosyphilis even along with primary and secondary leisons.26 
The likelihood of unusual presentations in secondary syphilis is greater when CD4+T cells count falls 
below 150/µl. About 5% of patients develop uveitis27 which is bilateral in half of these cases. Rapidly 
evolving cases of syphilitic aortitis28 have been reported.
Gumma
The ulcerative (or) nodular manifestations of benign tertiary syphilis are known as gummata. 
Syphilitic gumma remains uncommon in HIV seropositive indivudals. It may however be seen Immune 
reconstitution syndrome.29
Neuro syphilis
Every patient with primary syphilis develops spirochaetemia and is a risk of seeding the CNS 
and  developing  neurosyphilis.  The  immunological  response  of  a  patient  has  an  important  role  in 
controlling  the  infection,  even  in  presence  of  adequate  antibiotic  therapy.30 In  HIV  infection 
neurosyphilis  is  seen more often in younger  patients.  Rapid progression of early syphilis  to neuro 
syphilis with manifestations as meningitis (or) cranial nerve defects (Most commonly optic neuritis (or) 
deafness)  and   facial  nerve  also  seen.31,32,33,34 Also  quarternary  neurosyphilis  (ie.  necrotising 
encephalitis) is seen in HIV infected patients.35
Daniel et al.32 reported that the incidence of neurosyphilis in HIV infected patients. Despite 
receiving  treatment  in  the  recent  past  for  early  (or)  latent  syphilis,  has  greately  increased.  These 
observations  suggest  that  a  more  aggressive  approach  is  needed  to  treat  syphilis  in  HIV infected 
patients.
Diganosis
Serology
Clinically, in immuno competent patients the VDRL test is highly diagnositc. If it is 
negative (it is a strong evidence for excluding the disease. Atypical serological responses to 
treponemal infection have been described in  HIV infected patients.  These include,  delayed 
serological response to treponemal infection, accelerated loss of treponemal antibody following 
treatment,  decreased  antibody  production  to  treponemal  antigens,  conversely  significantly 
elevated RPR titres36 with advancing immunosuppression37 titres may change and indeed return 
to normal.
Hyper gamma globulinemia and polyclonal B cell activation, which are common early in 
the course of infection may lead to higher prevalence of "biological false positive" reaction.36 
Excess of non treponemal antibodies produced by HIV induced B cell dysfunction prevents the 
Antigen-Antibody  reaction  in  standard  test  by  the  prozone  phenomenon  resulting  in  false 
negative reaction.
When  the  clinical  findings  suggest  syphilis  but  serological  tests   are  negative  (or) 
inconclusive,  alternative  tests  such  as  dark  field  microscopy,  biopsy  of  the  lesion  for 
histopathological examination, immunoperoxidase techniques, and direct fluorescent antibody 
staining of materials obtained from lesions may be needed in these cases. Diagnosing neuro 
syphilis is also difficult because both HIV and  syphilis can cause a mononuclear pleocytosis 
and elevated protein in CSF. CSF VDRL can be negative in persons with neurosyphilis.37
Treatment
Lack of  response to penicillin therapy and relapse without exposure despite adequate 
treatment has been reported in many studies.38,39,40  Immunodeficiency induced by HIV appears 
to render the benzathine penicillin treatment ineffective in substantial proportion of cases.41
Jarisch - Herxheimer reaction in syphilis is more frequently seen among HIV infected 
early syphilis patients compared to non-HIV infected controls.42
As per the current WHO, CDC and NACO guidelines for the management of STD, 
recommended therapy for early syphilis in HIV infected patients is not different from that of 
non-HIV infected patients.
Single dose of Benzathine penicillin G  2.4 million I.U. I.M for early syphilis and four 
weekly doses of benzathine penicillin  G 2.4 million I.U. IM for late syphilis.
To ensure adequacy of treatment quantitative VDRL at 1,2,3,6,9,12 months should be 
done.
Chancroid
According to  Cameroon et al43 men with chancroid are almost 5 times more likely to 
acquire HIV than those with out GUD.
HIV induced immuno suppression increase the clinical severity of H.ducreyi infection, it 
may also reactivate  genital  herpes.44   Coinfection of  HSV with  chancroid may explain the 
increased number of ulcers in such patients.
Genital ulcers tend to be larger and persist longer. Multiple Inguinal buboes may be 
present. Frequent occurrence of giant and phagedenic ulcers can occur. Extragenital chancroids 
in digits and legs in association with penile lesions have also been documented.45
Treatment
Less responsive to standard therapy, 3-4 fold higher failure rate with single dose therapy 
with azithromycin and ceftriaxone has been noted.
Current reccommendations for treatment of chancroid in HIV infected patients are same 
as those  for  immuno competent  patients,  though patients  may require  a longer  duration of 
therapy with close follow-up.
Single dose regimens - Ceftriazone 250mg IM  Azithromycin 1g orally.,
(or) 
T. Erythromycin for 7 days (CDC 2002)
Herpes Genitalis
In 1987, the CDC revised the surveillance case definition for AIDS to include, several 
indicator diseases, the addition of herpes simplex virus infection being one of them.46 Chronic 
ulcers cased by HSV 2, of more than 1 month duration are an AIDS defining illness.
Invitro  studies  suggest  that  coinfection of  certain  cell  lines  with HSV and HIV can 
change the rate of HIV replication.  ICPO and ICPA, the early regulatory proteins of HSV 
transactivate the long terminal repeat of HIV-1. The transactivating protein of HSV, VP16 acts 
synergistically with HIV-1 Tat protein to increase HIV transcription for the HIV-1 LTR47.
The rate of subclinical shedding of HSV is significantly increased in patients infected 
with HIV. The most common site of shedding is the perianal area.
Clinically the lesions are atypical, large often haemorrhagic, deep painful ulcers with 
raised  margins.  Other  atypical  lesions  include  hyperkeratotic  verrucous  lesions  vegetating 
plaques and a zosteri form appearance.48
Although Mucocutaneous infections are the most common problem with HSV and HIV 
positive  persons,  extensions  of  infection  to  visceral  organs  has  been  reported,  including 
esophagitis, encephalitis retinitis, thrombocytopenia, mollarets' meningitis.
Diagnosis
Tzanck smear, biopsy and  culture are useful diagnostic tools.
Culture remains the Gold Standard.
Treatment
Mild to moderate mucocutaneous HSV
Oral acyclovir 200mg 5 times daily (or) 400mg 3 to 4 times daily till clinical resoltuion 
attained (7-10 days) (or)
Famcyclovir 500mg twice daily  x 5-10 days (or) valacyclovir 1 g daily x 5-10 day.
Acyclovir Resistance
Acyclovir resistant HSV should be suspected when HSV culture positive lesions persist 
despite adequate serum concentrations (>2mcg/ml) of acyclovir.
It was observed that with discontinuation of acyclovir and initiation of treatment with 
foscarnet a new isolate was recovered, characterised by loss of acyclovir resistant trait  and 
production of a functional thymidine - kinase enzyme.49
Treatement of ACV resistant HSV
Increase the dose of oral acyclovir to 800 mg 5 times a day. If there is no response after 
5-7 days and lesions are accessible, topical trifluridine every 8 hrs (or) topical 1% cidofovir gel 
once daily till the lesions heal can be tried. If lesions are inaccessible IV foscarnet 60mg / kg 
thrice a day (or) 40mg/kg thrice a day until complete healing  should  be given. Innunotherapy 
with interleukins can also be tried.
Foscarnet resistance has been reported and this may make cidofovir,  the most viable 
option.
Donovanosis
Being  a  genital  ulcer  it  facilitates  transmission  of  HIV.  Jamkhedkar  
et  al50   compared  the  clinical  features  and  response  to  treatment  in  genital  lesions  of 
donovanosis  in  both HIV sero positive  and seronegative  patients.  They conlcuded that  the 
former took a longer time to heal completely  (25.7 vs 16.8 days) and tended to produce greater 
tissue destruction and increased incidence of squamous cell carcinoma.51
Treatment
Erythromycin 500mg 4 times a  day for  14 days  in  quite  effective  (or)  Doxycycline 
100mg bd x 2-3 weeks can be given.
Lymphogranuloma Venereum
There is paucity of reports on LGV patients with concommitant HIV infection because 
the disease is not so common. One retrospective study has shown that HIV appears to have no 
adverse effect on clinical features of LGV.52
Treatment
Same line of treatment is recommended for LGV as in HIV negative patients, however 
with a longer course.
Doxycycline  100mg orally bd x 14 days
(or)
Erythromycin 500mg orally QID x 14 DAYS
Genital Warts
By weakening cell mediated immunity HIV has a profound effect on human papilloma 
virus  infection.  There  is  an  increased  incidence  of  Ano-genital  warts  in  HIV  seropositive 
individuals.53
Kirial et al54 demonstrated that HIV seropositive men are 3.1 times more likely to be 
positive for HPV DNA by PCR than seronegative men and that the former often have infection 
with multiple subtypes of HPV compared with the later.
Critchlow et al55 demonstrated that seropositive but symptomatic men were 4.1 times 
more likely to have anal HPV DNA detected by PCR.
HIV infected patients have multiple lesions and even diffuse involvemnet of the ano-
genital  areas.56 They develop very large genital  warts  and on rare  occasions these become 
locally invasive and destructive. These tumours  are called giant condylomas (or) Buschke-
Lowenstein  tumors.  They  do  not  cause  metastasis,54 but  carry  a  significant  risk  of 
transformation into squamous cell carcinoma.
The  chances  of  clinically  overt  HPV  infections  are  increased  in  HIV  seropositive 
individuals.56 HIV infection activates HPV early genes in a tissue specific manner favouring the 
perianal epithelium than the epithelium of penile shaft. Consequently perineum may mount a 
weak immune response and this local immunodeficiency may account for the higher rate of 
HPV occurence in the perianal area than on the penile shaft.57
In vitro studies have shown that intracellular HIV-1 tat m RNA can transactivate HPV 
type 16 E6 & E7 an action that is important in the development of squamous call cancers.54
Women with HIV infection appear to be at increased risk for HPV and related cervical 
intra epithelial neoplasia.Cervical cancer in an HIV sero positive patients is an AIDS defining 
illness.55
Diganosis
Usually anogenital warts are diagnosed on clinical ground, but in HIV infected patients 
biopsy  should  be  considered  so  that  dysplastic  changes  (or)  squamous  cell  cancer  can  be 
ascertained early in the disease to help the management process.
Treatment
It  remains  the  same  as  for  the  immunologically  normal  host.  However 
immunocompromised individuals have a much higher rates of reccurrences,56 Podophyllotoxin, 
imiquimod, cidofovir gel are useful. Excision and Electrodessication are advocated in frequent 
recurrences after topical treatment.57
CDC recommends two pap smears and pelvic examinations during the first year after the 
diagnosis of HIV and thereafter yearly pap smears and pelvic examination.
Molluscum contagiosum
Between  10% to  30% of  patients  with  symptomatic  HIV  disease   (or)  AIDS have 
molluscum contagiosum.58 Of the two types of  molluscum contagiosum viruses,  MC1 and 
MC2, MC2 is common in adult men and patients with HIV infection.59 The prevalence and 
severity of the disease increase with advancing immunodeficiency and lesions occur in upto 
one third of patients with CD4 + Tcell counts of 100/µL (or) lower.60
The individual lesions of MC can be quite large with a diameter of 10mm (or) more 
(GIANT MC), MULTIPLE (upto 100 lesions)  distributed over face, including the eye lids and 
ears, neck and in intertriginous areas like axilla, groin (or) buttocks. In homosexual men the 
lesions are often seen in ano-genital area.
Some times  the  lesions  may  resemble  comedones  abcesses,  furuncles,  condylomata, 
basal cell carcinoma, ecthyma and cutaneous horns. It is important to differentiate such lesions 
from keratoacanthoma, cryptococcosis, histoplasmosis, penicilliosis and coccidioidomycosis.
Viral structures consistent with MC are present in the clinically uninvolved epidermis 
adjacent to the lesions of MC in HIV infected patients. This may explain the large number of 
lesions seen in these patients and the difficulty in controlling the spread and recurrences of MC 
lesions.61
No therapy  is  very  effective  in  HIV seropositive  patients  as  new lesions  frequently 
develop.62 Intra lesional interferon - alpha results in Shrinkage of treated lesions but no effect 
on  surrounding  lesions.63 Imiquimod  may  be  considered.  Cidofovir  either  topical  (or) 
intravenous route may be effective in recalcitrant mollusca.64 Anti retrorival therapy is helpful 
in extensive and recalcitrant lesions. CDC reccommends needle prick.
Gonorrhoea and Non-gonococcal Urethritis
There are many reports showing statistically significant  association of gonorrhoea with 
HIV  seroconversions  with  risk  estimates  ranging  from 3  to  5.  Majority  of  the  studies  of 
gonorrhoea have examined male to female HIV transmission.
In a study from Baltimore, the risk of female to male HIV transmission was doubled in 
gonorrhoea  patients.65 There  are  also  few  anecdotal  reports  of  increased  recurrence  of 
gonorrhoea in HIV infected individuals.66
Human Herpes virus -8
Human herpes virus - 8 (HHV-8) was originally identified in Kaposis' sarcoma tissue 
from AIDS patients. It is also associated with a rare type of non-Hodgkins lymphoma, termed 
primary effusion lymphoma and with the plasma cell variant of castleman's disease.
It appears to be sexually transmitted infection in western Europe and USA.
Most  cases  of  AIDS  associated  KS  have  appeared  in  men  who  participated  in 
homosexual activities (or) had a history of STI.
Those persons who acquired HIV non sexually (hemophiliacs (or) IV drug abusers) have 
much  lower  rates  of  KS  than  those  who  contracted  HIV  from  homosexual  (or)  bisexual 
contacts.67 Many studies have focussed HHV-8 into semen.
Kaposi's sarcoma is characterised by a multifocal and wide spread distribution in HIV 
sero positive patients. Variety of lesions like patches plaques, papules, nodules and ulcers may 
appear any where on the skin (or) Mucous membrane. visceral involvement including the GIT, 
Lymphnodes and Lungs.
In  the  era  of  highly  active  antiretroviral  therapy  (HAART)  KS  is  seen  much  less 
commonly, suggesting that the development (or) resolution of KS is linked to immune system 
control of HHV-8.
Genital candidiasis
As  number  of  women  with  HIV  is  growing,  vaginal  candidiasis  is  increasingly 
reported.68 This is due to HIV related immunosuppression and frequent use of broad spectrum 
antibiotics administered for prophylactic and therapeutic purposes.
HIV associated recurrent vulvo-vaginal candidiasis requires constant systemic therapy 
for control of symptoms.68
Recurrent vulvo vaginal candidiasis (4 or more episodes of symptomatic VVC per year 
with  atleast  one  episode  confirmed  by  culture)  is  described  as  a  presenting  marker  of 
underlying HIV infectin.
Treatment of VVC resulted in a 3.2 fold reduction in the concentration of HIV in vaginal 
secretions.69
VVC is increased 6.8 times in women with CD4 +T-cell count less than 200 cells/µL.70 
Local mucosal immune milieu plays an important role in the development of oro-pharyngeal 
(or) vulvo-vaginal candidiasis than systemic CMI.71
Long-term prophylatic therapy with fluconazole 200mg weekly in HIV infected patients 
has been effective in reducing genital candidiasis.
Hepatitis "B&C"
There is no increased risk for rapid development of AIDS (or) declime in CD4 + cell 
counts in Hepatitis B virus (HBV) positive patients.72
HIV infected individuals are at  increased risk of acquisition of HBV and during acute 
HBV infection HIV seropositive patients tend to develop more severe illness. They are also at 
increased risk of chronic HBV infection.
It is also observed that the response of HIV infected persons to vaccination against HBV 
is impaired. Similar relations have been observed for HCV. The relationship between HCV and 
sporadic porphyria cutanea tarda in HIV sero positive patients is well documented.
Scabies
The clinical features of scabies in the HIV positive patients are often determined by the 
degree of immune suppression. As the immunity decreased (CD4+cells <200/  µL) the more 
contagious and fulminant forms of scabies become apparent.73,74
The unusual  forms  of  scabies  in  HIV seropositive  patients  can be  divided  into  two 
overlapping categories, papular and crusted (Norwegian (or) hyperkeratotic)
These patients may harbour thousand of scabies mites.  The crusts can serve as food 
supply and protection; sustaining the mites for upto a week.75
Treatment recommendations are same  as for HIV negative patients.
Sexually transmitted gastro intestinal pathogens
Sexually transmitted intestinal pathogens have increased in number over the past several 
years in patients with AIDS, especially those practising anal (or) oral sex.
The  sexually  transmitted  GI  pathogens  are  cryptosporiduim  parvum.  Isospora  belli, 
giardia lamblia entamoeba histolytica, cyclospora spp, N.Gonorrhoea, viruses like CMV, HSV, 
Adeno, HPV, HBV and fungi like candida albicans, bacteria like salmonella spp Shigella spp. 
campylobacter spp.
A wide variety of anorectal lesions have been described including ulcers, fissures, fistula 
and abscess. The most common pathogens were CMV and HSV-2.
Anorectal HSV in HIV infected patients tends to develop chronic progressive disease 
leading to large destructive perianal ulcers.
Rectal gonorrhoea increases the risk of HIV acquisition three fold.76
Cryptosporidium is the  most widely recognised enteric pathogen with a world wide 
distribution  of  10%  to  20%  in  patients  with  AIDS77 cryptosporidiosis  is  a  chronic  and 
protracted  disease  and  is  a  cause  of  wasting  syndrome  (or)  "SLIM  DISEASE"  in  AIDS 
patients.  Crypotosporidium can  be  diagnosed  by  stool  examination  (or)  intestinal  aspirate. 
Spiramycin and parmomycin are effective.
Amoebiasis is, common and is a cause of "gay bowel syndrome".
EPIDEMIOLOGY
Agent : Human Immuno Deficiency Virus (HIV)
HIV, the etiological agent of AIDS, belongs to the lentivirus subgroup of the family 
retroviridae. HIV is a RNA virus, a cyto pathic virus. 2 major types are HIV -1 and HIV 2.
There are three groups of HIV -1 group "M" (major), group "O" (outlier) and group 
"N".The M group comprises eight subtypes (or) clades designated A,B,C,D,F,G,H and J and as 
well as four major circulating recombinant forms.
HOST FACTORS
The  major  cell  surface  receptor  for  HIV-1  is  CD4  differentiation  antigen.  CD4  is 
expressed  on  T  helper  lymphocytes  and  less  densely  on  Macrophages,  Dendritic  cell  and 
microglial cells. Another receptor called "galactosyl ceramide" can also serve as a receptor for 
HIV in glial and neuroblastoma cell lines.78 However expression of CD4 receptor on the cell 
surface is not enough to allow HIV entry into the cells.  Feng et al79 showed that a protein 
designated FUSIN (or) CXCR acted preferentially as coreceptors for T-cell line tropic HIV-1 
isolates. The CC- Chemokine receptor - 5 (CCR-5) is considered the main corecptor used by 
macrophage - trophic HIV -1 strains. The role of CCR-2 is not established.
During the early phase, virus propagates mainly in peripheral blood mononuclear cells. 
HIV infection usually elicits strong cell mediated immune response (CD8 + Cytotoxic T-cells) 
which  helps  to  clear  the  high  viral  load  but  fail  to  eradicate  HIV  infection.  During 
asymptomatic period, virus is active in lymphoid tissue. In untreated pateints after a variable 
period, CD4  T cell count falls below a critical level and patient becomes highly susceptible to 
opportunistic diseases.
The main endogenous factors that regulate HIV expression are cytokines and exogenous 
factors are other microbes with effects on HIV replication.
Coinfections upregulate HIV expression and accelerate the progression. The virus during 
early,  asymptomatic  phase  are  non syncytium inducing  variants  and during  late  stages  are 
syncytium inducing variants.
TRANSMISSION OF HIV
Sexual transmission
In India the epidemic spreads primarily through sexual route. According to phylogenetic 
analysis most of Indian HIV-1 strains belong to sub type "C". Sexual  transmission can occur 
following vaginal and anal inter course and also potentially through oral sex.80 Male to female 
transmission is twice as effective as female to male transmission.81
Transmission through pregnancy and breast feeding
HIV infection to the fetus / new born may  occur during Intrauterine, peripartum and 
post partum periods. 50% - 70% of transmission occurs at  (or) around the time of delivery with 
30% - 50% in utero. The risk of post partum infection from breast feeding is estimated to be 
approximately 15% - 30%.
Blood - borne Transmission
The  association  between  the  transfusion  of  blood  products  and  AIDS  was  first 
recognised in 1982. Donor screening and HIV testing of donors can prevent HIV transmission 
from blood and blood products. HIV infected injecting drug users may transmitant HIV  by 
syringe (or) needle sharing.
Occupational Exposure
Health care workers are at risk through a percutaneous injury by needles or other sharp 
instruments. The risk is estimated to be approximately 0.3%.
Organ and Tissue Donation
HIV   transmission  can  occur  following  the  transplantation  of  human  organs  (or) 
following bone graft transplanation from infected donors.82
Household transmission, casual contact and insect factors
There is  substantial  epidemiological  data available  that  HIV transmission not  occurs 
through hugging (or) kissing, sharing clothes or eating and drinking utensils.83 There is also no 
evidence that insects can act as vectors for transmission.
Clinical staging of HIV disease
Acute seroconversion syndrome
It is the symptom complex that is experienced by 80-90% of patients but is infrequently 
registered. The time of onset is 2-4 weeks from expsoure. This presents as influenza - like 
illnes (or) as infectious mononucleosis like illness.
Early HIV Disease
Most of the individuals are asymptomatic with CD4 cell count greater than 500 cells / 
mm3 Generalised  lymphadenopathy  is  the  most  common  manifestation.  Dermatologic 
abnormalities like sebrrhecic dermatitis, Eosinophilic folliculitis etc are common.
Intermediate Stage
Also called  as  symptomatic  HIV infection corresponds  to  category  B,  CDC clinical 
classification with CD4 count between 200-500 cells / mm3 AIDS state (or) late stage
This stage in characterized by opportunistic infections and malignancies described in 
table I. It corresponds to CDC category C classification with CD4 cell count 50-200 cells / mm3
Advanced HIV disease
In this stage CD4 count less than 50 cells / mm3 with infections like Mycobacterium 
avium  complex,  cytomegalovirus  retinitis,  disseminaled  fungal  infections,  AIDS  dementia 
complex.
AIMS
1. To  study  the  prevalence  of  various  sexually  transmitted  diseases  in  HIV  patients 
attending the well health clinic. (WHC)
2. To study the morphological patterns of various sexually transmitted diseases in HIV 
patients.
3. To analyse the clinical course and recurrences of sexually tranmitted diseases and its 
impact on the progression of HIV disease.
4. To  study  the  response  to  treatment  of  various  sexually  transmitted  diseases  in  the 
presence of HIV infection.
5. To study the prevalence of mixed infections in the presence of HIV infection
MATERIALS AND METHODS
Study Design
Prospective observational study
Sample
The study population comprised of HIV seropositive patients with coexistent STD. They 
are registered during the period from 1st May 2004 to 31st December 2005, in the Institute of 
Venereology Madras Medical College, Chennai. During the study period a total number of 102 
male  patients  and  148  female  patients  with  HIV  sero  positivity  and  coexistent  sexually 
transmitted disease were registered and observed.
Methods
The study patients were interviewed for their presenting complaints, sexual history, past 
history of venereal diseases and other systemic illnesses and treatment taken. All the patients 
were  counselled  on STD's  and genital  hygiene,  sexual  practices  and regular  treatment  and 
follow up. They were given pre and post test counselling.
All  the  patients  underwent  a  complete  physical  and  genital  examination.  All  these 
patients  were  clinically  analysed for  the  genital  manifestation and supported  by  laboratory 
diagnosis.
Screening  for  sexually  transmitted diseases  were  done.  Serological  tests  for  syphilis 
including blood VDRL and TPHA was performed. Patients were investigated for oppurtunistic 
infections and classified into various categories of HIV infection according to CDC and NACO 
guidelines.
In the case of genital ulcers, the following tests were done.
a. Dark ground examination for treponema pallidum
b. Gram's stain for Haemophilus ducreyi and candida
c. Tissue smear and leishman stain for calymmatobacterium granulomatis
d. Tzanck test for giant multinucleated epithelial cells.
e. Ziehl-Neelson  staining for mycobacterium tuberculosis.
In the case of genital discharge the following tests were done
a. Wet film for trichomonas vaginalis
b. 10% potassium hydroxide preparation for candida albicans
c. Gram's stain to identify Neisseria gonorrhoeae, candida albicans and clue cells in 
urethral and cervical smears.
In addition the examination of urine, culture of Neisseria gonorrhoeae from specimens 
of urethral discharge and urine for the male and from the endo cervical swab for the female 
were done.
In case of genital growth, histopathological examination of biopsy specimen was done 
for appropriate cases. Pus and discharge from ulcers were subjected to culture and sensitivity in 
needed cases.
Routine  baseline  laboratory  analysis  including  complete  blood  count,  renal  function 
tests, liver function tests, random blood sugar, chest x-ray, ultrasonogram abdomen, were done 
for all patients. Sputum smear for AFB, mantoux test, Culture and sensitivity, blood and urine 
culture and sensitivity, peripheral blood smear for malaria, blood widal were also done for the 
need.
 In needed symptomatic patients, opinion from concerned specialists like dermatology, 
dental, opthalmology, chest clinic, cardiology, neurology and gastroenterology were obtained. 
They  were  offered  standard  treatment  according  to  clinical  condition  and  prophylaxis  for 
oppurtunistic infections.
RESULTS
TABLE 1 
Domicile by sex
Domicile Male Female No %
Rural 58
(56.86%)
96
(64.86%)
154
(61.6%)
61.6%
Urban 44
(43.14%)
52
(35.14%)
96
(38.4%)
38.4%
Total 102 148 250 100
TABLE 2 
Nativity of patients
State
Male Female
No. % No. %
No. %
Tamil 
Nadu
71 69.60% 107 72.29 179 71.2
Andhra 
Pradesh
28 27.45 39 26.35 67 26.8
Other 
States
3 2.95 2 1.36 5 2
One fifty four cases (61.6%) belonged to rural area and 96 (38.4%) belonged to urban 
area.  Majority  of  cases  178  (71.2%)  belonged  to  Tamilnadu  and  Andhra  Pradesh  (67 
(26.8%).The  age  group  ranges  from 15-54  years.  Majority  of  patients  (73  males  and  103 
females)  belonged to the highly active sexual age group of  20-40 years. Unfortunately this is 
also the age group that is economically productive in any society.
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NATIVITY OF PATIENTS
Male
Female
TABLE 3
Age group of patients
Age Group
Male Female
No. % No. %
< 20 14 13.7 33 22.3
20-30 51 50 57 38.5
30-40 22 21.6% 46 31.1
40-50 12 11.8 11 7.4
>50 3 2.9 1 0.7
Total 102 100 148 100
TABLE 4
Literacy of patients
Educational 
State
Male Female
No. % No. %
No. %
Illiterate 26 25.49 35 23.65 61 24.4
Primary 49 48.04 86 58.11 135 54.0
Secondary 22 21.57 24 16.22 46 18.4
College 5 4.90 3 2.02 78 3.2
Total 102 100 148 100 250 100
Among the 250 patients 61 were illiterate (24.4%), 135 (54%)  had primary education 
and 54 (21.6%)  had secondary and college education. This data clearly shows that uneducated 
are clearly lacking awareness about HIV infection.  It also suggests that visual media rather 
than print media will be more effective in reaching the target population.
TABLE 5
Occupation of the patient
Occupation
Male Female
No. % No. %
No. %
Agriculture labour 27 26.4 17 11.4 44 176
Drinker 21 20.6 0 - 21 8.4
Semskilled/ unskilled labour 29 28.4 26 17.5 55 22.0
Sales/Business 12 11.8 0 - 12 4.8
Officer goers 2 1.96 6 4.1 8 3.2
CSW - - 10 6.8 10 4
Housewife - - 89 60.2 89 35.6
Others 11 10.9 - - 11 4.4
Regarding  occupational  status,  most  of  the  (56)  male  patients  are  agricultural  (or) 
unskilled/semiskilled workers belonging to the lower socio economic strata.  Among female 
patients, majority of them are house wives and economically dependant. The so-called high-
risk groups such as drivers and salesman (33) are one third of the total no of male patients. That 
is 13.2% of the total study population.
TABLE 6
Marital Status of the Patients
Marital Status
Male Female
No. % No. %
No. %
Married 67 65.07 87 58.8 154 61.6
Unmarried 23 22.06 14 9.5 37 14.8
Kept 2 1.9 6 4.1 8 3.2
Separated 4 3.9 22 14.9 26 10.4
Widow/Widower 6 5.9 19 12.7 25 10.0
Total 102 100 148 100 250 100
Majority of the patients in study group are married 154 (61.6%), 37 are unmarried, 26 
are married and separated and 25 widowed.
TABLE 7
Sexual Exposure History
Sexual Exposure
Male Female
No. % No. %
No. %
Marital Only 8 7.8 117 79.1 125 50
Premarital 29 28.4 6 4.1 35 14
Extramarital 17 16.6 14 9.5 31 12.4
Pre and Extra marital 48 47.2 11 7.3 59 23.6
Total 102 100 148 100 250 100
Regarding  sexual  exposure,  male   patients  have  more  premarital  and  extramarital 
contacts 46 (45%) when compared to females 20 (13.6%). Another significant aspect is 79.1% 
of females had only marital contact and acquired infertion only from their husbands.
TABLE 8
Age at first sexual exposure
Age at first 
sexual expsoure
Male Female
No. % No. %
No. %
< 20 yrs 19 18.6 91 61.5 110 44
21-30 59 578 37 25 96 38.4
30-40 24 23.6 20 13.5 44 17.6
Total 102 100 148 100 250 100
Regarding the age at first sexual expsoure majority of males, 81.4% are between the 
20-40 age groups when compared to females 91 cases (61.5%) had their first sexual exposure 
below 20 years. This can be attributed to the early marriages which are common in our rural 
areas.
TABLE 9
Recent premarital / Extra marital exposure
Duration
Male Female
No. % No. %
No. %
No premarital (or) 
extra marital sex
8 7.8 117 79.1 125 50
< 6 month 42 41.2 11 7.4 53 21.2
6 months - 2 years 16 15.6 7 4.78 23 9.2
> 2 years 36 35.4 13 8.8 49 19.6
Total 102 100 148 100 250 100
41.2%  of  males  had  premarital  contact  until  6  months  recently  while  35.44%  had 
premarital contacts before 2 years during which period they might have acquired their HIV 
infection. 79% females (117) have acquired their STD and HIV through their married contact.
TABLE 10
Probable routes of HIV transmission to patients
Route of 
tranmission
Male Female
No. % No. %
No. %
Hetero sexual 78 76.4 145 97.9 223 89.2
Homosexual 6 5.9 - - 6 2.4
Bisexual 9 8.9 - - 9 3.6
Blood transfusion 3 2.9 3 2.1 6 2.4
Injection drug use 6 5.9 - - 6 2.4
Total 102 100 148 100 250 100
Heterosexual sexual transmission remains the most common mode of HIV transmission 
223 (89.2%) cases were noted. Homosexual (2.4%), Bisexual (3.6%) together forms the next 
major group. 6 patients (2.4%) who denied sexual exposure gave history of blood transfusion. 
Two of them are married and living together and one separated. Partners of the two were also 
found positive.
TABLE 11
HIV status of the Patients Partners
HIV Status
Male Female
No. % No. %
Total
No partners and unknown partners 27 26.4 21 14.2
KNOWN PARTNERS
Positive 62 60.8 103 69.6 165
Negative 4 3.9 5 3.4 9
Status not known (separated) 9 8.9 19 12.8 28
  102 100 148 100 250
60.8% of male patients and 69.6% of female patients had their partners positive. Nine 
discordant couples were noted.
TABLE 12
Previous venereal diseases of patients
Previous venereal 
diseases
Male Female
No. % No. %
No. %
No History 52 50.9 86 58.1 138 55.2
Genital Ulcers 36 35.3 14 9.5 50 20
Genital Discharge 6 5.9 46 31.1 52 20.8
Other STD's 8 7.9 2 1.3 10 4
Total 102 100 148 100 250 100
As per the history elicited  from the patients 36 (35.3%) and 14 (9.5%) of male and 
female patients respectively gave history of genital ulcers. 55.2% of total study group did not 
give history of previous venereal diseases.
TABLE 13
Presenting complaints of the patients
Complaints
Male Female
No. % No. %
No.
Ulcers 15 14.7 14 9.5 29
Vesicles 6 5.9 4 2.7 10
General Discharges 3 2.9 53 35.8 56
Growths 11 10.8 15 10.1 26
Bubo 2 1.9 3 2.1 5
Itching 5 4.9 9 6.1 14
Burning Micturition 5 4.9 12 8.1 17
Other genital complaints 2 1.9 4 2.7 6
Skin complaints 29 28.4 11 7.4 40
Check - up 24 23.7 23 15.5 47
Total 102 100 148 250
Fifteen cases (14.7%)  of male patients and Fourteen cases (9.5%) of female patients 
presented with complaints of Genital ulcer, eleven cases (10.8%) of males and fifteen (10.1%) 
of females gave complaints of growth.
Three  cases (2.9%) of  male patients  and 53 (35.8%) female patients  presented with 
complaints of discharge. Forty seven reported for  checkup.
TABLE 14
Various STDs in HIV Positives
STD
Male Female
No. % No. %
No.
Primary syphilis 3 2.9 2 1.4 5
Secondary syphilis 8 7.8 2 1.4 10
Early latent syphilis 5 4.9 3 2.1 8
Late Latent syphilis 2 1.9 6 4.1 8
Benign tertiary syphilis 1 0.9 - - 1
Herpes progenitalis 20 19.6 21 4.2 41
Chancroid 3 2.9 1 0.7 4
Donovanosis - - 1 0.7 1
LGV* 1 0.9 - 1
Chronic genital ulcer 4 3.9 1 0.7 5
Gonorrhoea 2 1.9 2 1.4 4
Cevicitis - 4 2.7 4
Epididimorchitis 1 0.9 - 1
Candidiasis (VVC) - 21 14.2 21
Trichomoniasis - 12 8.1 12
Bacterial vaginosis - 15 10.1 15
PID* - 3 2.1 3
Balanoposthitis (Candidal) 7 6.9 - 7
NGU* 4 3.9 4 2.7 8
Genital Warts 9 8.8 12 8.1 21
Genital Molluscum 6 5.9 2 1.4 8
Scabies 2 1.9 3 0.7 3
Mixed Infection 24 23.5 33 23.6 59
Total 102 100 148 100 250
*LGV - Lymphogranuloma venereum 
*PID - Pelvic inflammatory Disease
* NGU - Non-Gonococcal Urethritis
Among 102 male patients 78 (76.5%) had atleast one sexually transmitted disease and 
24 (23.5%) had multiple STD's and mixed infection. Among 148 female patients 113 (76.4%) 
had atleast one sexually transmitted disease and 34 (23.6%) had mixed infections.
Ninety three (37.2%) cases of ulcerative STD were recorded in this study. The major 
etiological factor for the ulcerative STD among HIV positive patients is herpes progenitalis 64 
cases (25.6%) had herpes progenitalis, that is one fourth of study population. Growths (Warts 
and Mollusca) encountered in HIV positive patients were 44 (17.6%) in both male and female 
patients. In females discharging STD's were 91(61.5%) either alone (or) as mixed infections, 
are the most common STDs encountered among HIV positive patients.
TABLE 15
Mixed infection and multiple STDs
MALE
Herpes and Wart - 6
Herpes Genitalis and Candidiasis - 6
Syphilis and Herpes  Genitalis - 4
Wart and Mollusum contagiosum - 3
Scabies and Balanoposthitis - 2
Wart and chancroid - 1
Total - 24
FEMALE
*CVV and *BV - 7
CVV and *TVV - 6
Cervicitis and TVV - 6
Cervicitis and BV - 5
Candidiasis and warts - 5
Herpes genitalis and candidiasis - 2
PID and CVV - 1
Total - 33
* CVV - Candidal vulvo vaginosis
* BV - Bacterial vaginosis
* TVV - Trichomonas vaginalis vaginosis
* PID - Pelvic Inflammatory disease
Among  male patient herpes coexisting with wart (or) molluscum contagosium is the 
common mixed infection. Herpes occuring in latent syphilis cases has also been found. Among 
female patients discharging STDs due to mixed organisms are the commonest.
Table -16
Associated skin manifestations
Male Female
No. % No. %
IBA 9 8.8 10 6.8
Impetigo / folliculitis 5 4.9 - -
Herpes simplex 2 1.9 - -
H. Zoster 3 2.9 1 0.7
Sebborrheic dermatitis 18 17.7 17 11.5
Psoriasis 1 0.9 - -
Deematophytosis 2 1.9 12 8.1
Drug eruption 2 1/9 3 2.1
Intertrigo 3 2.9 12 8.1
Lichen Planus 2 1.9 - -
Scrofulo Derma 1 0.9 - -
Eczema 4 3.9 4 2.7
Scabies 5 4.9 3 2.1
Mixed infections
Wart x dermatophyte 4 3.9 1 0.7
MC x dermatophyte 3 2.9 3 2
64 (62.8%) male patients had dermatological manifestation atleast once during the study 
period  while  72  (48.7%)  female  patients  had  dermatological   manifestations.  Sebborrheic 
dermatitis is the most common dermatological manifestation of HIV in this study. Exaggerated 
IBA and folliculitis are the next common skin manifestation.
One fifty four cases had oral candidiasis among which 68 cases are male and 86 cases 
are female, atleast once during the study period. Twenty one cases had oral hairy leukoplakia 
(OHL) and two male patients had genital Lichen sclerosus et atrophicus.
Table -17
Mucosal Lesions
Mucosal Lesions Male Female
Oral candidiasis 68 86
Oral hairy leukoplakia 14 7
Genital LSA 2 -
Total 84 93
* LSA -  Lichen sclerosus et atrophicus
Table -18
Anogenital Herpes
Clinically 1st Episode 6
Recurrent Cases 53
MORPHOLOGICAL PATTERNS
Typical Morphology 47
Atypical Morphology 12
RECURRENCES
> 6 / year 12
< 6 / year 41
Table -19
Response to treatment in genital candidiasis
Total cases 51
Followup 41
2% clotrimazole 25
2% clotrimazole + Fluconazole 16
Recurrences 10
Table -20
Response to treatment in Ano-genital Warts
Total cases 36
Followup 33
Podophyllin 25
Podophyllin + Cryo 8
Recurrences 6
DISCUSSION
The high prevalence of STD's in HIV positives underlines the importance of infectivity 
and suceptibility cofactors in HIV transmission and acquisition. This shows the importance of 
early diagnosis and management of STDs to control HIV transmission and acquisition.
Sexual transmission was the most important independent risk factor (93 males and 145 
females) for HIV infection detected in this study. A large proportion of individuals engaged in 
sexual practices with promiscuity,  early age of first  sexual exposure and infrequent use of 
condoms. History of previous venereal diseases and present STD's were associated with higher 
risk of HIV acquisition.
So our study high lights the importance of reinforcing surveillance, early diagnosis and 
combined strategies to control and manage STD's and HIV. STD clinics in India are important 
sites for conducting HIV surveillance and risk reduction education.
Syphilis
Thirty six (14.4%) cases of syphilis, (23 male and 13 female) were encountered in this 
study. 5 cases were primary syphilis, 10 cases of secondary syphilis, 8 cases of early latent, 8 
cases of late latent syphilis and one case of benign tertiary syphilis were found. Four cases of 
herpes genitalis with latent syphilis were found.
Among primary syphilis one case had multiple chancres and one case presented with 
erosions. Among 10 cases of secondary syphilis 4 cases  had features of secondary syphilis 
with primary chancre not completely healed. The average range of healing of both primary and 
secondary lesions after treatment was 30-40 days. 
According to Malone and Coworkers, treatment failures occurred 12 to 24 months after 
therapy in 18% of the patients, substantially beyond the period of observation used in most 
syphilis treatment studies.
Regarding VDRL reactivity, reactive serology varied from 1 to 64 dilutions and 13 cases 
had >  16 dilutions.
Gonorrhoea
4  cases  of  Gonorrhoea  were  found  in  this  study.  All  of  them  were  treated  with 
ceftriaxone injections. 2 had post Gonoccoccal urethritis and were treated with doxyclycine.
Chancroid
4 cases of chancroid were found, one case of giant chancroid was found which required 
longer  duration  of  treatment  when  compared  to  average.  i.e.
12-14 days of treatment.
Donovanosis
A single case of Granuloma inguinale is noted in this study.The biopsy showed chronic 
inflammatory infiltration consisting of lymphocytes, monocytes and plasma cells with pseudo 
epitheliomatis hyperplasia. No complication was noted.
LGV
One case  of   of  LGV bubo was found and presented with bilateral  painful  inguinal 
lymphadenitis with groove sign. The patient responded to two weeks of doxycycline treatment.
One case of Epididymoorchitis and 3 cases of PID, all responded to combined anti biotic 
regimens
Vaginal Discharge
Fifty  four  cases  of  discharging  STDs  including  both  Bacterial  vaginosis  (30)  and 
Trichomonas  vaginalis  (24)  were  noted,  either  alone  (or)  mixed.  Among  these  all  cases 
responded to  standard  metronidazole  regimen  except  8  cases  of  Bacterial  vaginosis  which 
needed prolonged treatment with metronidazole for 2 weeks.
Candidiasis
Fifty one  cases  (Male - 9, Female - 42) of candidiasis (both balano posthitis and vulno 
vaginal candidiasis) were found in this study. 
Out of forty one who came for follow up, 25 patients responded to clotrimazole therapy 
while 15 required added systemic therapy with fluconazole . 10 patients showed recurrences.
Scabies
Seven  cases  of  scabies  were  encountered  and  all  cases  were  treated  with  single 
application of 1% gama bezne hexa chloride. Five cases required second application after two 
weeks.
Mollusum contagiosum
Out  of  8  cases  of  MC.  6  responded  to  simple  expression  of  contents  with  forceps 
followed by  cryo.  2  had atypical  presentations  giant  and dimenminated typer  and required 
multiple cyro sessions.  4 cases reported back with recurrences.
Genital Warts
Thirty six cases of genital warts were noted in this study. 19 cases were male and 17 
cases were female. Thirty three cases came for regular followup. Twenty five cases responded 
to podophyllin application and eight cases required podophylline and cryo. Among the thirty 
three cases who came for follow up, six  patients (18.2%) had recurrences.
Chirgwin et al reported  that the incidence of venereal warts was 8.2 compared with 0.8 
per 100 persons - years of follow up for HIV-1 seropositive and HIV -1 seronegative patients 
respectively. 
Biopsy of the watts showed hyperkeratosis, papillomatosis and koilocytosis.
Ano genital herpes
Fifty nine cases of  Ano-genital herpes (36 males and 23 females) were encountered  in 
this  study.  It  is  the  most  commonst  ulcerative  STD  found  among  HIV  positive  patients 
according to this study.
Six cases reported with first clinical episode. Fifty three cases were recurrent. Thirty six 
cases  showed  typical  morphological  features.  Twenty  three  cases  had  either  Atypical 
morphological features (or) a protracted course. Out of these twenty three cases 12 cases had 
recurrences > 6 / year.
Thirty six cases responded to T.Acyclovir 400mg tds for a period for 7-10 days, the 
maximum being 400 mg tds for a period of 4 weeks.
Atypical  morphological   presentations  including  chronic  ano-genital  ulcerations 
required increased dosage for prolonged periods. 
Chronic Ano-genital ulcers
5 cases of chronic  anogenital ulcers (an ulcer showing no signs of healing after more 
than one month) were found in this study. 2cases  had features of tuberculosis with choronic 
inflammatory infiltration of lymphocytes and macrophages with caseation necrosis. One case 
showed mitotic figures with nuclear atypia suggestive of squamous cell carcinoma. One case 
who is a homosexual was stool positive for entamoeba histolytica. 
The most common ulcerative STD among HIV positive patients is herpes progenitalis 
according  to  this  study.  The  Atypical  prersentations  rquired  modification  in  dosage  and 
duration of treatment schedule. There is no much difference in prevalence of syphilis in HIV 
and non HIV patients, although  the healing time of primary chancre was found to be increased 
and coexisting primary and secondary syphilis lesions were found in a significant numbe of 
cases in this study. Coexistence of herpes with other genital ulcers and other eitologies were 
also found. The  lesions persisted with (or) without antibacteiral treatment.
The antibiotic prescriptions for various prophylactic measures or oppurtunistic infections 
and therapeutic for various systemic illness  have decreased the prevalence of most bacterial 
STD's like gonorrhoea, chancroid, according to this study. This has been largely replaced by 
viral STD's like herpes, Warts and Mollusum contagiosum.
The current  study has limitations because the gold standard laboratory techniques like 
MPCR, culture and antibody detection for viral and  chlamydia infections are not used.
The increased prevalence of genital warts and mollusum contagiosum was most likely as 
a result of reduced ability of immune system to control infection. Also infection of the non-
lesional normal skin may explain the difficulty in treating these viral infections due to frequent 
recurrences lack of HPV DNA typing has led to the inability of typing of HPV.
Prolonged treatment course and recurrences were noticed for both bacterial vagnosis and 
vulno vaginal candidasis. 
Few cases who had the benefit of receiving HAART showed improvement in immunity 
with consequent clearance of warts and MC lesions.
CONCLUSION
The high prevalence of STD's among HIV positive  patients suggest that the patients 
have not altered their sexual behaviour pattern. 95.2% of the patients had acquired their HIV 
infection through sexual transmission. 70.4% of the patients belong to the sexually active and 
economically productive age group of 20-40 years.
Ninety three cases (37.2%) of ulcerative STD's were recorded in this study. The major 
etiological factor for the ulcerative STD among HIV positive patients is Herpes progenitalis. It 
accounts for 59 cases (23.6%) of the total study group. Thirty six cases of syphilis (14.4%) 
were noted. Ano-genital growths (Wart and Mollusum) accounted for 44 cases (17.6%) of the 
total study group. Discharging STDs are the major STD's  noted in female patients. There  were 
91 cases (36.4%) either alone (or) mixed, were noted in this study. One thirty six cases (54.4%) 
had dermatological  manifestations  among which seborrheic dermatitis  is  the  most  common 
dermatological manifestation, in HIV according to this study. Based on the above prevalence 
data, ulcerative STDs are common in males while discharging STD's are common in females 
among HIV positive patients.
STD's due to viral etiology accounted for 106 cases, far out numbering the bacterial, 
fungal and protozoal causes. Thus according to this study viral STDs' are more common in HIV 
positive patients.
Atypical  morphological  patterns,  protracted  course,  delayed  healing  time,  frequent 
recurrences after complete treatment were noted in syphilis,  herpes progenitalis,  chancroid, 
candidiasis, anogenital warts in this study. But this involved only in a small proportion of cases 
except in herpes progenitalis in which 23 out of 59 cases showed atypicality.
Majority of the patients responded to usual treatment that is given to patient with out 
HIV infection. There were no complications during treatment.
Mixed infections accounted for 57 cases (22.8%) in this study. They are becoming more 
common in HIV infected patients when compared with the normal population.
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PROFORMA
PREVALENCE OF STD IN HIV PATIENTS
STD No.: Serial No : Date :
Name : Age : Sex : Male/ Female
Domicile : Rural Urban
State : Tamilnadu Andhra Pradesh Other States
Marital Status : Married Kept Unmarried
Separated Widow/Widower
Educational Status : Illiterate Primary Secondary College
Occupation
• Agriculture Worker
• Driver
• Semiskilled labour
• Unskilled labour
• Sales/Businessmen
• Officegoers
• Housewife
• Commercial sex worker
• Others
Partners HIV Status : • Positive • Negative • Notknown
• Unknown or No partners
Age at First Sexual Exposure < 20 years, 20-25 years, > 26 years.
H/o. Sexual exposure : Marital Premarital
Extramarital Promiscuous
Recent premarital/ extramarital exposure
Nil < 6 months 6 months - 2 years > 2 years
Probable route : Heterosexual, Homosexual, Bisexual, 
Blood transfusion, injecting drug use.
History of treatment for HIV infection :
No treatment ART Symptomatic'
OI prophylaxis Alternative medicines
Previous venereal disease: No history Ulcers
Discharges Others
Presenting complaints :
Ulcer Vesicles Discharge
Growth Bubo Itching
Burning micturition Skin rash Systemic Checkup
Duration of HIV since diagnosed : < 1 year 1-3 years > 3years
Clinical Presentation
Skin GIT CNS Musculoskeletal Others
RS CVS Ophthalmic STD's
GENITAL LESIONS
Genital ulcers - Dark  field  for  Treponema  pallidum,  Grams 
stain  for  haemophilus  ducreyi,  candida,  Tissue  smear  for 
calymmatobacterium granulomatis.
Tzanck terst for giant multinucleated epithelial 
cells.
AFB staining for tubercle bacilli
Scrapings for Itchmite, phthirus pubis lice.
GENITAL DISCHARGE
- Wet film for Trichomonas, Candida (Saline, 10% KOH)
- Gram's  stain  for  neisseria  gonorrhoeae,  candida  albicans,  clue  cells  in 
bacterial vaginosis from urethral and cervical smearl.
Culture of neisseria gonorrhoea from discharge in both males and female.
Urine Examination
Urine culture and Sensitivity
Pus and discharge culture and sensitivity for general bacterial infections.
Genital Growth  : Biopsy and histopathological examination
Blood VDRL TPHA HBs Ag
Other Investigations :
Complete blood count Liver function tests Renal function tests
Chest X-ray Sputum for AFB Mantoux Test
Sputum culture and sensitivity USG Abdomen and Pelvis
Blood widal Blood smear for malaria
ECG CT Scan brain
Diagnosis Treatment Followup
CONSENT FORM
I  _______________________________________ hereby agree that I  shall  get  myself 
involved in the study of Prevalence of STD in HIV Patients  and give my consent for blood 
investigations, biopsy and scrapings and other investigations, be performed on me.
Date : Signature of the patient
Signature of witness with name
Signature of Investigator
